Schonfeld Strategic Advisors’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-273,579
| Closed | -$2.12M | – | 2397 |
|
|
2025
Q3 | $2.12M | Buy |
273,579
+46,625
| +21% | +$350K | 0.01% | 1001 |
|
|
2025
Q2 | $1.68M | Sell |
226,954
-77,609
| -25% | -$682K | 0.01% | 1076 |
|
|
2025
Q1 | $2.62M | Buy |
304,563
+219,780
| +259% | +$3.39M | 0.02% | 824 |
|
|
2024
Q4 | $3.03M | Sell |
84,783
-4,149
| -5% | -$215K | 0.02% | 671 |
|
|
2024
Q3 | $4.2M | Sell |
88,932
-30,145
| -25% | -$1.33M | 0.03% | 604 |
|
|
2024
Q2 | $5.98M | Buy |
119,077
+78,731
| +195% | +$5.69M | 0.05% | 499 |
|
|
2024
Q1 | $4.52M | Sell |
40,346
-5,230
| -11% | -$520K | 0.04% | 686 |
|
|
2023
Q4 | $2.64M | Buy |
+45,576
| New | +$1.83M | 0.02% | 709 |
|
|
2023
Q3 | – | Sell |
-12,822
| Closed | -$1.05M | – | 2110 |
|
|
2023
Q2 | $1.05M | Buy |
+12,822
| New | +$1.88M | 0.01% | 946 |
|
|
2022
Q4 | – | Sell |
-3,446
| Closed | -$583K | – | 2867 |
|
|
2022
Q3 | $583K | Buy |
+3,446
| New | +$560K | ﹤0.01% | 1649 |
|
|
2022
Q2 | – | Sell |
-2,116
| Closed | -$211K | – | 2832 |
|
|
2022
Q1 | $211K | Buy |
+2,116
| New | +$247K | ﹤0.01% | 1920 |
|
|
2021
Q3 | – | Sell |
-900
| Closed | -$306K | – | 2369 |
|
|
2021
Q2 | $306K | Sell |
900
-936
| -51% | -$354K | ﹤0.01% | 1461 |
|
|
2021
Q1 | $743K | Sell |
1,836
-4,297
| -70% | -$2.08M | 0.01% | 1002 |
|
|
2020
Q4 | $4.08M | Buy |
6,133
+2,427
| +65% | +$1.35M | 0.06% | 444 |
|
|
2020
Q3 | $1.73M | Buy |
3,706
+1,729
| +87% | +$874K | 0.03% | 546 |
|
|
2020
Q2 | $1.16M | Buy |
1,977
+357
| +22% | +$122K | 0.03% | 569 |
|
|
2020
Q1 | $236K | Buy |
1,620
+1,200
| +286% | +$210K | 0.01% | 850 |
|
|
2019
Q4 | $60K | Buy |
+420
| New | +$30.7K | ﹤0.01% | 1228 |
|
|
2018
Q2 | – | Sell |
-418
| Closed | -$165K | – | 890 |
|
|
2018
Q1 | $165K | Buy |
+418
| New | +$165K | 0.01% | 697 |
|
|
2017
Q3 | – | Sell |
-1,400
| Closed | -$489K | – | 726 |
|
|
2017
Q2 | $489K | Buy |
+1,400
| New | +$484K | 0.05% | 394 |
|
Other funds holding MRSN
NI
BCLSI
RSCM
AV
AAA
